DOLENE AP-65 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dolene Ap-65, and when can generic versions of Dolene Ap-65 launch?
Dolene Ap-65 is a drug marketed by Lederle and is included in one NDA.
The generic ingredient in DOLENE AP-65 is acetaminophen; propoxyphene hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; propoxyphene hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOLENE AP-65?
- What are the global sales for DOLENE AP-65?
- What is Average Wholesale Price for DOLENE AP-65?
Summary for DOLENE AP-65
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 11 |
DailyMed Link: | DOLENE AP-65 at DailyMed |
US Patents and Regulatory Information for DOLENE AP-65
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | DOLENE AP-65 | acetaminophen; propoxyphene hydrochloride | TABLET;ORAL | 085100-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |